Elias Jabbour, Maria R. Baer, Anthony Hunter, Dennis Dong Hwan Kim, Vivian G. Oehler, Huanshan Guo, Zi Chen, Zhihong Yang, Tommy Fu, Dajun Yang, Yifan Zhai, Hagop M. Kantarjian. "Olverembatinib (HQP1351) combined with blinatumomab in patients with lymphoid blast phase chronic myeloid leukemia (CML-LBP) or Philadelphia chromosome–positive B-cell precursor acute lymphoblastic leukemia (Ph + BCP-ALL).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.6513